• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用有序逻辑回归将皮肤病生活质量指数(DLQI)得分映射为欧洲五维健康量表(EQ-5D)效用值。

Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression.

作者信息

Ali Faraz Mahmood, Kay Richard, Finlay Andrew Y, Piguet Vincent, Kupfer Joerg, Dalgard Florence, Salek M Sam

机构信息

Department of Dermatology and Academic Wound Healing, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK.

School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.

出版信息

Qual Life Res. 2017 Nov;26(11):3025-3034. doi: 10.1007/s11136-017-1607-4. Epub 2017 Jun 10.

DOI:10.1007/s11136-017-1607-4
PMID:28601958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5655589/
Abstract

PURPOSE

The Dermatology Life Quality Index (DLQI) and the European Quality of Life-5 Dimension (EQ-5D) are separate measures that may be used to gather health-related quality of life (HRQoL) information from patients. The EQ-5D is a generic measure from which health utility estimates can be derived, whereas the DLQI is a specialty-specific measure to assess HRQoL. To reduce the burden of multiple measures being administered and to enable a more disease-specific calculation of health utility estimates, we explored an established mathematical technique known as ordinal logistic regression (OLR) to develop an appropriate model to map DLQI data to EQ-5D-based health utility estimates.

METHODS

Retrospective data from 4010 patients were randomly divided five times into two groups for the derivation and testing of the mapping model. Split-half cross-validation was utilized resulting in a total of ten ordinal logistic regression models for each of the five EQ-5D dimensions against age, sex, and all ten items of the DLQI. Using Monte Carlo simulation, predicted health utility estimates were derived and compared against those observed. This method was repeated for both OLR and a previously tested mapping methodology based on linear regression.

RESULTS

The model was shown to be highly predictive and its repeated fitting demonstrated a stable model using OLR as well as linear regression. The mean differences between OLR-predicted health utility estimates and observed health utility estimates ranged from 0.0024 to 0.0239 across the ten modeling exercises, with an average overall difference of 0.0120 (a 1.6% underestimate, not of clinical importance).

CONCLUSIONS

This modeling framework developed in this study will enable researchers to calculate EQ-5D health utility estimates from a specialty-specific study population, reducing patient and economic burden.

摘要

目的

皮肤病生活质量指数(DLQI)和欧洲五维健康量表(EQ - 5D)是两种不同的测量方法,可用于收集患者与健康相关的生活质量(HRQoL)信息。EQ - 5D是一种通用测量方法,可从中得出健康效用估计值,而DLQI是一种用于评估HRQoL的特定专科测量方法。为了减轻多种测量方法带来的负担,并能够针对疾病进行更具体的健康效用估计计算,我们探索了一种既定的数学技术,即有序逻辑回归(OLR),以开发一个合适的模型,将DLQI数据映射到基于EQ - 5D的健康效用估计值。

方法

将来自4010名患者的回顾性数据随机分五次分为两组,用于映射模型的推导和测试。采用折半交叉验证,针对年龄、性别以及DLQI的所有十个项目,为五个EQ - 5D维度中的每一个维度总共生成十个有序逻辑回归模型。使用蒙特卡罗模拟得出预测的健康效用估计值,并与观察到的估计值进行比较。对OLR和先前基于线性回归测试的映射方法都重复了此方法。

结果

该模型显示出高度预测性,其重复拟合表明使用OLR以及线性回归的模型都很稳定。在十次建模练习中,OLR预测的健康效用估计值与观察到的健康效用估计值之间的平均差异范围为0.0024至0.0239,总体平均差异为0.0120(低估1.6%,无临床意义)。

结论

本研究中开发的这个建模框架将使研究人员能够从特定专科的研究人群中计算EQ - 5D健康效用估计值,减轻患者负担和经济负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/766c/5655589/c2dfe2736f6f/11136_2017_1607_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/766c/5655589/c2dfe2736f6f/11136_2017_1607_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/766c/5655589/c2dfe2736f6f/11136_2017_1607_Fig1_HTML.jpg

相似文献

1
Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression.使用有序逻辑回归将皮肤病生活质量指数(DLQI)得分映射为欧洲五维健康量表(EQ-5D)效用值。
Qual Life Res. 2017 Nov;26(11):3025-3034. doi: 10.1007/s11136-017-1607-4. Epub 2017 Jun 10.
2
Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.从皮肤病生活质量指数生成 EQ-5D-3L 效用评分:一项针对银屑病患者的映射研究。
Value Health. 2018 Aug;21(8):1010-1018. doi: 10.1016/j.jval.2017.10.024. Epub 2017 Dec 26.
3
Mapping of Family Reported Outcome Measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values.将家庭报告结局测量量表(FROM-16)评分映射至 EQ-5D:计算效用值的算法。
Qual Life Res. 2024 Apr;33(4):1107-1119. doi: 10.1007/s11136-023-03590-z. Epub 2024 Feb 25.
4
Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study.利用全国健康和福利研究中特应性皮炎患者的数据,将皮肤病生活质量指数(DLQI)评分映射到 EQ-5D 效用评分。
Qual Life Res. 2020 Sep;29(9):2529-2539. doi: 10.1007/s11136-020-02499-1. Epub 2020 Apr 15.
5
Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities.将 DLQI 映射到银屑病的 EQ-5D 中:将皮肤特异性健康相关生活质量转化为效用。
Arch Dermatol Res. 2013 Apr;305(3):197-204. doi: 10.1007/s00403-012-1309-2. Epub 2012 Dec 25.
6
Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.将SRS-22r问卷映射到青少年特发性脊柱侧凸患者的EQ-5D-5L效用评分上。
PLoS One. 2017 Apr 17;12(4):e0175847. doi: 10.1371/journal.pone.0175847. eCollection 2017.
7
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.探讨 EQ-5D、DLQI 和 PASI 之间的关系,并对 EQ-5D 效用进行映射:来自匈牙利的银屑病横断面研究。
Eur J Health Econ. 2014 May;15 Suppl 1:S111-9. doi: 10.1007/s10198-014-0600-x. Epub 2014 May 16.
8
Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile Equating.使用线性和等百分位等价法将 PROMIS 全球健康项目映射到 EuroQol(EQ-5D)效用评分。
Pharmacoeconomics. 2017 Nov;35(11):1167-1176. doi: 10.1007/s40273-017-0541-1.
9
[Assessment of health-related quality of life in psoriasis patients in Hungary].[匈牙利银屑病患者健康相关生活质量评估]
Orv Hetil. 2018 May;159(21):837-846. doi: 10.1556/650.2018.31061.
10
EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.EQ-5D健康效用值:探索改善银屑病反应性的方法。
J Med Econ. 2017 Jan;20(1):19-27. doi: 10.1080/13696998.2016.1219359. Epub 2016 Aug 15.

引用本文的文献

1
Mapping Dermatology Life Quality Index with EQ-5D health utility index score in Chinese patients with moderate to severe psoriasis.中国中重度银屑病患者皮肤病生活质量指数与EQ-5D健康效用指数评分的映射关系
J Comp Eff Res. 2025 Sep;14(9):e250039. doi: 10.57264/cer-2025-0039. Epub 2025 Jul 18.
2
Comparison of health-related quality of life in atopic dermatitis, hidradenitis suppurativa, pemphigus and psoriasis.特应性皮炎、化脓性汗腺炎、天疱疮和银屑病患者健康相关生活质量的比较。
Arch Dermatol Res. 2025 Jan 18;317(1):291. doi: 10.1007/s00403-024-03786-4.
3
Alitretinoin versus phototherapy as the first-line treatment in adults with severe chronic hand eczema: the ALPHA RCT.

本文引用的文献

1
A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.一项针对银屑病随机对照试验中使用生活质量工具的系统评价。
Br J Dermatol. 2017 Mar;176(3):577-593. doi: 10.1111/bjd.14788. Epub 2016 Oct 12.
2
A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-5D-derived utility values.一项系统的文献综述,旨在使用EQ-5D得出的效用值比较银屑病与其他慢性疾病的生活质量。
Patient Relat Outcome Meas. 2015 Jul 7;6:167-77. doi: 10.2147/PROM.S81428. eCollection 2015.
3
Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis.
阿利维 A 酸酯与光疗作为成人重度慢性手部湿疹一线治疗的比较:ALPHA RCT。
Health Technol Assess. 2024 Oct;28(59):1-123. doi: 10.3310/TWQC0141.
4
Mapping Kansas City cardiomyopathy, Seattle Angina, and minnesota living with heart failure to the MacNew-7D in patients with heart disease.将堪萨斯城心肌病、西雅图心绞痛和明尼苏达州心力衰竭患者的 MacNew-7D 图谱绘制到心脏病患者中。
Qual Life Res. 2024 Aug;33(8):2151-2163. doi: 10.1007/s11136-024-03676-2. Epub 2024 Jun 5.
5
Mapping of Family Reported Outcome Measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values.将家庭报告结局测量量表(FROM-16)评分映射至 EQ-5D:计算效用值的算法。
Qual Life Res. 2024 Apr;33(4):1107-1119. doi: 10.1007/s11136-023-03590-z. Epub 2024 Feb 25.
6
Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study.开发从肺癌患者 FACT-L 估算 EQ-5D-5L 的算法:一项映射研究。
Qual Life Res. 2024 Mar;33(3):805-816. doi: 10.1007/s11136-023-03567-y. Epub 2023 Dec 26.
7
Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective.司库奇尤单抗与其他生物制剂治疗中重度斑块状银屑病的成本效益:中国医疗保健系统视角
Dermatol Ther (Heidelb). 2023 Nov;13(11):2681-2696. doi: 10.1007/s13555-023-01041-8. Epub 2023 Sep 23.
8
Estimating health related quality of life effects in vitiligo. Mapping EQ-5D-5 L utilities from vitiligo specific scales: VNS, VitiQoL and re-pigmentation measures using data from the HI-Light trial.估算白癜风患者的健康相关生命质量影响。使用 HI-Light 试验数据,从 VNS、VitiQoL 和复色测量等白癜风专用量表出发,对 EQ-5D-5L 效用值进行映射。
Health Qual Life Outcomes. 2023 Aug 10;21(1):85. doi: 10.1186/s12955-023-02172-4.
9
Mapping of disease-specific Oxford Knee Score onto EQ-5D-5L utility index in knee osteoarthritis.膝关节骨关节炎中疾病特异性牛津膝关节评分与 EQ-5D-5L 效用指数的映射关系。
J Orthop Surg Res. 2023 Feb 2;18(1):84. doi: 10.1186/s13018-023-03522-0.
10
Health utilities for non-melanoma skin cancers and pre-cancerous lesions: A systematic review.非黑色素瘤皮肤癌和癌前病变的健康效用:一项系统综述。
Skin Health Dis. 2021 Jun 4;1(3):e51. doi: 10.1002/ski2.51. eCollection 2021 Sep.
皮肤病生活质量指数(DLQI)评分与工作限制问卷(WLQ)之间的相关性,有助于计算银屑病患者的工作生产力损失百分比。
Arch Dermatol Res. 2015 Jul;307(5):451-3. doi: 10.1007/s00403-015-1567-x. Epub 2015 May 5.
4
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.个体预后或诊断多变量预测模型的透明报告(TRIPOD):TRIPOD声明
BMC Med. 2015 Jan 6;13:1. doi: 10.1186/s12916-014-0241-z.
5
The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries.皮肤病的心理负担:一项针对13个欧洲国家皮肤科门诊患者的横断面多中心研究。
J Invest Dermatol. 2015 Apr;135(4):984-991. doi: 10.1038/jid.2014.530. Epub 2014 Dec 18.
6
The minimum clinically important difference for EQ-5D index: a critical review.EQ-5D指数的最小临床重要差异:一项批判性综述。
Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):221-33. doi: 10.1586/14737167.2014.894462.
7
Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities.将 DLQI 映射到银屑病的 EQ-5D 中:将皮肤特异性健康相关生活质量转化为效用。
Arch Dermatol Res. 2013 Apr;305(3):197-204. doi: 10.1007/s00403-012-1309-2. Epub 2012 Dec 25.
8
The role of the EQ-5D in the economic evaluation of dermatological conditions and therapies.EQ-5D 在皮肤科疾病和疗法的经济评估中的作用。
Dermatology. 2012;225(1):45-53. doi: 10.1159/000339865. Epub 2012 Aug 25.
9
Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.EQ-5D-5L 的临时评分:将 EQ-5D-5L 映射到 EQ-5D-3L 值集。
Value Health. 2012 Jul-Aug;15(5):708-15. doi: 10.1016/j.jval.2012.02.008. Epub 2012 May 24.
10
Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.三种中重度银屑病结局指标分析:基于注册研究的 2450 例患者。
Br J Dermatol. 2012 Apr;166(4):797-802. doi: 10.1111/j.1365-2133.2011.10778.x. Epub 2012 Mar 12.